NVAX vs ORKA Stock Comparison

Compare NVAX vs ORKA on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.

Market data as of Nov 15, 2026 market close
NVAX
Healthcare
vs
ORKA
Healthcare
NVAX
Novavax, Inc.
Price
$8.53
Day move
-2.68%
AIQ Score
-/100
Best edge
Balanced
Sector
Healthcare
ORKA
Oruka Therapeutics, Inc.
Price
$105
Day move
+0.34%
AIQ Score
77/100
Best edge
Quality
Sector
Healthcare

What is the main difference between NVAX and ORKA?

NVAX and ORKA are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.

AlgovestIQ AIQ Comparison

Novavax, Inc. vs Oruka Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictFragile

NVAX and ORKA are effectively level

NVAX and ORKA are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.

Evidence agreement: 0 of 4
NVAX

Novavax, Inc.

AIQ Score
—/100
AIQ Edge Score
—
ORKA

Oruka Therapeutics, Inc.

AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score does not currently separate NVAX and ORKA as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.

Compare Novavax, Inc. and Oruka Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

NVAX
-32.7%
ORKA
+313.1%

Total return comparison

Growth of $10,000, distributions reinvested

NVAX $6,728 · ORKA $41,314

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare NVAX and ORKA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

NVAX advantage
0
ORKA advantage
  • Quality62 vs 83
    ORKA +21
  • Risk Resilience38 vs 53
    ORKA +15
  • Momentum77 vs 81
    ORKA +4

Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

NVAX

Largest factor move: Momentum +3

No signal started or stopped since the prior session; its 6 active signals are unchanged.

ORKA+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)

Deeper signal detail for each name lives on its own signals page — NVAX and ORKA both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

Even

Neither separates on the overall score.

Growth

NVAX

NVAX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ORKA

ORKA on the Momentum factor, by 4 points.

Lower downside

ORKA

ORKA on Risk Resilience, by 15 points.

Analyst upside

ORKA

ORKA on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureNVAXORKANote
Implied upside to target-6.2%+9.2%ORKA has more room
Target dispersion0%+13%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering913Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

How each independent group of evidence reads the pair.

Evidence groupFavorsReading
AIQ ScoreNot coveredNot covered
FundamentalsNVAXEPS growth 40.6% vs 4.5%; TTM ROE 14.5% vs -4.2%
ValuationNot coveredNot covered
TechnicalsORKAPrice vs 50-day -19.1% vs 17.5%; vs 200-day -8.7% vs 45%
Risk ResilienceORKARisk Resilience 38 vs 53
Analyst expectationsORKATarget upside -6.2% vs 9.2%

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • Only 0 of 4 covered evidence groups agree. (argues the conclusion is provisional)

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

NVAXConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only NVAX

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • BB Lower Band Breach — bullish, volatility, short horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
ORKAConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ORKA

  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ORKAConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.34%, AIQ +1 points).

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

NVAX leads on balance
MetricNVAXORKA
Revenue growth (YoY)20.5%0%
EPS growth (YoY)40.6%4.5%
Gross margin77.3%0%
Operating margin-19.6%0%
Return on equity (TTM)14.5%-4.2%
Debt to equity-1.360

Performance

ORKA leads 5 of 6 windows
MetricNVAXORKA
1 week (5 sessions)-20.9%2.4%
1 month (20 sessions)-24.3%46.5%
3 months (63 sessions)5.6%-6.5%
6 months (126 sessions)-5.9%70.1%
Year to date26.9%247.6%
1 year (252 sessions)18.4%272.3%

Technicals

ORKA has the stronger structure
MetricNVAXORKA
RSI (14)37.664.4
ADX (14)2435.2
Price vs 50-day-19.1%17.5%
Price vs 200-day-8.7%45%
Volatility (1M, annualized)97.1%64.3%

Risk

ORKA is the more resilient
MetricNVAXORKA
Beta2.121.4
Sharpe ratio0.562.29
Sortino ratio0.934.3
Max drawdown-34.6%-36.4%
Current drawdown-33.5%-6.8%
Annualized volatility73.6%69.1%
Value at risk (95%)-6.1%-5.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which has more analyst upside, NVAX or ORKA?

Analyst price targets imply -6.2% upside for NVAX and +9.2% for ORKA, so the Street currently favors ORKA. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, NVAX or ORKA?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, NVAX or ORKA?

NVAX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, NVAX or ORKA?

ORKA on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, NVAX or ORKA?

ORKA is the more resilient of the two, so the other name carries the higher downside risk. ORKA on Risk Resilience, by 15 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is NVAX more profitable than ORKA?

NVAX leads on the comparable margin measures — gross margin 77.3% vs 0%; operating margin -19.6% vs 0%; ttm roe 14.5% vs -4.2%.

What do the current signals say about NVAX and ORKA?

NVAX: 2 bullish / 2 bearish / 2 neutral, conflicted. ORKA: 4 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NVAX is Golden Cross Active (bullish, long horizon). On ORKA it is Golden Cross Active (bullish, long horizon).

Compare NVAX and ORKA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.